Tag: higher-sales
-
U.S. drugmaker Biogen’s profit beats Street; CEO to leave
(Reuters) – Biogen Inc's quarterly adjusted profit blew past Wall Street estimates on higher sales of its multiple sclerosis drugs, and the company said Chief Executive George Scangos would leave in the coming months. Shares of the company, whose board also authorized a $5 billion share repurchase program, rose about 5 percent to $276 in…
-
Theranos hires executives to lead regulatory and compliance push
(Reuters) – Theranos Inc hired two executives to oversee regulatory, quality and compliance standards, in a bid to turn around the struggling blood-testing company after it received sanctions from U.S. regulators.